We are live on
!
Find out more
ONC
BeOne Medicines Ltd
123 hedge funds and large institutions have $6.12B invested in BeOne Medicines Ltd in 2018 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 40 increasing their positions, 37 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
455% more call options, than puts
Call options by funds: $58.2M | Put options by funds: $10.5M
282% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 11
127% more capital invested
Capital invested by funds: $2.69B → $6.12B (+$3.43B)
38% more funds holding in top 10
Funds holding in top 10: 8 → 11 (+3)
32% more funds holding
Funds holding: 93 → 123 (+30)
8% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 37
0.57% more ownership
Funds ownership: 4.66% → 5.23% (+0.57%)
Holders
123
Holders Change
+30
Holders Change %
+32.26%
% of All Funds
2.82%
Holding in Top 10
11
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+37.5%
% of All Funds
0.25%
New
42
Increased
40
Reduced
37
Closed
11
Calls
$58.2M
Puts
$10.5M
Net Calls
+$47.7M
Net Calls Change
+$51.6M
Top Buyers
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$93M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$42.4M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
-$24.4M |
| 4 |
Brown Advisory
Baltimore,
Maryland
|
-$19M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$15.6M |
